ScholarIQanswers from OpenAlex

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry

PaperCitations, authors & open-access status

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry have?

ScholarIQcitation count

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry has 37 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry published?

ScholarIQyear

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry has 2022 year in the ScholarIQ index.

What is the open-access status of Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry?

ScholarIQoa status

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry has green oa status in the ScholarIQ index.

What is the DOI of Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry?

ScholarIQdoi

The DOI for Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry is on the source record.

What is the PMID of Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry?

ScholarIQpmid

The PMID for Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry is on the source record.

What is the OpenAlex record for Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry?

ScholarIQopenalex

The OpenAlex for Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial